BOSTON, Oct. 24, 2024 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy to treat herniated discs, announced today that the American Medical Association (AMA) CPT Editorial Panel has...
Intrinsic Therapeutics Announces New Category 1 CPT Code for Bone Anchored Annular Closure, including the Barricaid® Annular Closure Device, to Treat Patients Undergoing Lumbar Discectomy for Herniated Discs
Seaking AlphaSeeking Alpha / Seaking Alpha 11 hours ago 1 Views
Comments